• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Assort Health Raises $26M for Specialty-Specific GenAI Platform for Managing Patient Phone Calls

by Fred Pennic 04/16/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Assort Health, a company specializing in AI solutions for managing patient phone calls in healthcare, has announced a new round of institutional financing co-led by First Round Capital and Chemistry, with continued support from existing investor Quiet Capital, bringing the company’s total funding to $26M.

– The funding will be used to accelerate Assort Health’s mission of improving access to care by addressing the issues of long hold times and scheduling inefficiencies that commonly affect healthcare organizations.

Specialty-Specific Generative AI Platform for Managing Patient Phone Calls

Founded by Jon Wang and Jeff Liu, Assort Health aims to solve the problems stemming from traditional healthcare call centers that often struggle with inefficient scheduling systems and high staff turnover (approximately 45% annually). These issues lead to long wait times for patients, resulting in abandoned calls, frustration, and obstacles to accessing necessary care.  

Assort Health’s core offering is an AI-powered voice agent that provides a solution to these challenges. The company’s technology is already being used by numerous healthcare organizations, including Chesapeake Healthcare, OrthoIndy, Peninsula Orthopaedic Associates, and Cleaver Medical Dermatology.

Key features and impact of Assort Health’s platform include:

  • Adaptability to healthcare specialties: The AI integrates with electronic health record systems to update patient data and insurance information and schedule appointments in real-time. It is designed to be adaptable to the specific needs of different specialty practices. The platform also includes an intuitive dashboard for managing AI agent “fleets.”  
  • High scheduling accuracy: Assort Health’s system is designed to achieve 99% scheduling accuracy by breaking down patient interactions into clear steps and using specialized AI agents.  
  • High resolution rate: The platform maintains a resolution rate of over 90%, which the company attributes to thousands of specialty-specific tests and continuous automated system testing. This high resolution rate aims to ensure reliable patient service and prevent errors such as misdirected referrals.  

To support further product development and commercial expansion, Assort Health plans to expand its team, particularly in engineering roles. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |